Antipruritic activity of the κ-opioid receptor agonist, TRK-820

This publication has 27 references indexed in Scilit:

• The novel κ-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice
  Life Sciences, 2001
• TRK-820, a Selective κ-Opioid Agonist, Produces Potent Antinociception in Cynomolgus Monkeys
  The Japanese Journal of Pharmacology, 2001
• A Novel κ-Opioid Receptor Agonist, TRK-820, Blocks the Development of Physical Dependence on Morphine in Mice
  Life Sciences, 2000
• Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
  Life Sciences, 1999
• Randomised crossover trial of naltrexone in uraemic pruritus
  Published by Elsevier ,1996
• Mast-Cell Heterogeneity: Functional Comparison of Purified Mouse Cutaneous and Peritoneal Mast Cells
  Journal of Investigative Dermatology, 1990
• The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis
  British Journal of Dermatology, 1990
• Role of Opioid Receptors in Bombesin‐induced Groominga
  Annals of the New York Academy of Sciences, 1988
• Substance P-Induced Histamine Release in Human Cutaneous Mast Cells
  Journal of Investigative Dermatology, 1987
• Treatment of pruritus due to chronic obstructive liver disease.
  BMJ, 1984